Myelodysplasia-like syndrome and end-stage liver disease - Report of 2 cases

被引：1
|
作者：
Keung, YK
Morgan, D
Hodges, D
Blann, M
Cobos, E
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Div Hematol Oncol, Lubbock, TX 79430 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Div Gastroenterol, Dept Internal Med, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA
来源：
ACTA HAEMATOLOGICA | 2001年 / 105卷 / 02期
关键词：
alpha(1)-antitrypsin deficiency; cirrhosis; myelodysplastic syndrome; primary biliary cirrhosis;
D O I：
10.1159/000046543
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report 2 cases of myelodysplastic syndrome associated with cirrhosis caused by primary biliary cirrhosis and al-antitrypsin deficiency. The etiology of myelodysplasia and its implication in liver transplantation is discussed. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码：100 / 102
页数：3
相关论文
共 50 条
  • [31] Management of End-Stage Liver Disease in Chronic Hepatitis B
    Tan, Hui-Hui
    Martin, Paul
    CLINICS IN LIVER DISEASE, 2010, 14 (03) : 477 - +
  • [32] Important predictor of mortality in patients with end-stage liver disease
    Kim, Hyung Joon
    Lee, Hyun Woong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (02) : 105 - 115
  • [33] The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
    Lim, Young-Suk
    Kim, W. Ray
    CLINICS IN LIVER DISEASE, 2008, 12 (04) : 733 - +
  • [34] Spur cell anemia in end-stage liver disease: a zebra!
    Shah, Rushikesh
    Patel, Arpan
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2014, 32 (08) : 944.e3 - 944.e4
  • [35] Vasopressin Deficiency and Vasodilatory State in End-Stage Liver Disease
    Wagener, Gebhard
    Kovalevskaya, Galina
    Minhaz, Moury
    Mattis, Fallon
    Emond, Jean C.
    Landry, Donald W.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 25 (04) : 665 - 670
  • [36] Organ allocation for chronic liver disease: model for end-stage liver disease and beyond
    Asrani, Sumeet K.
    Kim, W. Ray
    CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (03) : 209 - 213
  • [37] Palliative medicine and hospital readmissions in end-stage liver disease
    Rush, Barret
    Fruhstofer, Clark
    Walley, Keith R.
    Celi, Leo Anthony
    Brahmania, Mayur
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2024, 14 (E1) : e677 - e682
  • [38] Efficacy and Safety of Atazanavir in Patients with End-Stage Liver Disease
    Guaraldi, G.
    Cocchi, S.
    Motta, A.
    Ciaffi, S.
    Codeluppi, M.
    Bonora, S.
    Di Benedetto, F.
    Masetti, M.
    Floridia, M.
    Baroncelli, S.
    Pinetti, D.
    Bertolini, A.
    Gerunda, G. E.
    Esposito, R.
    INFECTION, 2009, 37 (03) : 250 - 255
  • [39] Individualized Management of Coagulopathy in Patients with End-Stage Liver Disease
    Tomic Mahecic, Tina
    Baronica, Robert
    Mrzljak, Anna
    Boban, Ana
    Hanzek, Ivona
    Karmelic, Dora
    Babic, Andela
    Mihaljevic, Slobodan
    Meier, Jens
    DIAGNOSTICS, 2022, 12 (12)
  • [40] Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease-sodium alone to predict mortality and liver transplantation
    Trivedi, Hirsh D.
    Danford, Christopher J.
    Iriana, Sentia
    Ochoa-Allemant, Pedro
    Rourke, Meredith
    Yang, Kuen-Cheh
    Curry, Michael P.
    Lai, Michelle
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E753 - E757
12345